Archives
-
Separating Growth Inhibition from Cancer Cell Killing
2026-09-28
Hannah R. Schwartz’s dissertation shows why relative viability and fractional viability should not be treated as interchangeable measures of anticancer drug response: they capture growth inhibition and cell killing, which can differ in magnitude and timing. The distinction supports more careful assay selection and interpretation, including when applying these concepts to compounds such as chlorambucil that were not evaluated in the dissertation.
-
RNase Alert-Plus: Evidence and Workflow Scope
2026-09-27
RNase Alert-Plus (SKU K1903) is listed by APExBIO, but the supplied product dossier does not describe its assay chemistry or performance. A separate 2026 study reports that a two-component cationic liposome platform delivered mRNA and induced CD8+ T-cell responses in mice; it did not evaluate RNase Alert-Plus.
-
TaqI Restriction Endonuclease: Practical Guide
2026-09-26
TaqI Restriction Endonuclease provides sequence-specific digestion of plasmid DNA, PCR products, or genomic DNA in a short incubation for cloning and other molecular biology workflows. Use it only when the target DNA contains the recognition site and follow the product instructions for reaction conditions; it is for research use, not diagnostic or medical applications.
-
Cy3 Goat Anti-Rabbit IgG (H+L) Antibody
2026-09-25
This Cy3-conjugated secondary antibody detects rabbit primary antibodies in fluorescence-based workflows, including immunofluorescence, IHC, ICC, and flow cytometry. It is for research use only; optimize the working dilution and staining conditions for each sample and do not use it for diagnostic, medical, or unvalidated live-cell applications.
-
Total RNA Extraction Reagent (Trizol) for Biofilms
2026-09-25
Explore how Total RNA Extraction Reagent (Trizol) can support RNA preparation for studies of Acinetobacter baumannii biofilm biology. This guide connects recent single-cell findings to practical decisions about bulk RNA extraction, sample handling, and interpretation—while clarifying what extraction can and cannot reveal.
-
Cell Counting Kit-8 (CCK-8): Reliable Assay Design
2026-09-24
A practical guide to choosing, optimizing, and interpreting Cell Counting Kit-8 (CCK-8) for cell viability, proliferation, and cytotoxicity studies. It explains workflow considerations for SKU K1018, including assay controls, readout conditions, and the limits of interpreting metabolic signal as cell number.
-
HyperScript First-Strand cDNA Synthesis Kit Guide
2026-09-24
The HyperScript First-Strand cDNA Synthesis Kit uses engineered HyperScript Reverse Transcriptase to make first-strand cDNA from purified total RNA or poly(A)+ RNA. Its primer choices and stated long-template capability support PCR amplification and qPCR workflows, while the product description does not provide a complete reaction protocol or performance benchmark.
-
HyperScript III RT SuperMix for CRC qPCR
2026-09-23
HyperScript III RT SuperMix combines reverse transcription with genomic DNA cleanup for two-step qRT-PCR workflows. Its product specifications describe HyperScript III Reverse Transcriptase as suitable for challenging RNA, while a 2026 colorectal cancer study offers research markers—not clinical tests—for follow-up gene expression analysis.
-
Calcium Lactate Nanomedicine for Colorectal Cancer
2026-09-23
The reference study introduces a calcium lactate nanoparticle that co-delivers bufalin and a CRISPR-Cas9 ribonucleoprotein targeting CD47 to combine tumor-cell death with immune reprogramming. Its multimodal design links pyroptosis, apoptosis, macrophage M1 polarization, and enhanced phagocytosis, providing a preclinical framework for local tumor control and systemic antitumor immunity.
-
Ibrexafungerp: From MICs to In Vivo Evidence
2026-09-22
Ibrexafungerp and MK 3118 connect standardized susceptibility testing with delayed-treatment evidence against resistant Candida auris. This article explains how to interpret MIC data, select translational models, and avoid overextending preclinical findings.
-
Calpeptin Workflows for Fibrosis and Cell Death
2026-09-22
Calpeptin enables controlled inhibition of calcium-dependent calpain activity in fibroblast, inflammation, and regulated cell-death studies. This guide connects pulmonary fibrosis models with discriminating apoptosis and necrosis assays, emphasizing practical dosing, controls, and troubleshooting.
-
MLN4924: A Translational Map for Neddylation Biology
2026-09-21
MLN4924 is a selective NEDD8-activating enzyme inhibitor that converts neddylation pathway inhibition into a measurable strategy for studying CRL function, proteostasis, cell-cycle control, and cancer biology. This thought-leadership guide connects molecular mechanism with experimental design, competitive positioning, and translational decision-making.
-
TaqI Restriction Endonuclease Protocol
2026-09-21
TaqI Restriction Endonuclease provides rapid, sequence-specific cleavage of plasmid DNA, PCR products, and genomic DNA containing the TCGA recognition site. It is intended for scientific research workflows such as cloning and fragment analysis, not for diagnostic, clinical, or medical use.
-
qPCR Strategy for Exosome Osteolysis Research
2026-09-20
A mechanism-led guide to applying hot-start SYBR Green qPCR in translational studies of exosome-based strategies for periprosthetic osteolysis, with practical guidance on assay design, validation, reproducibility, and research positioning.
-
COVID-19 mRNA Vaccines and Cancer Immunotherapy
2026-09-19
The reference study links COVID-19 mRNA vaccination with improved responses to immune checkpoint inhibition through retrospective clinical analyses and mechanistic mouse experiments. Its findings suggest that an existing vaccine platform can stimulate innate immunity and tumor T-cell infiltration, while also highlighting the need for prospective trials and careful formulation studies.